The meprin A homo-oligomer is a highly glycosylated, secreted zinc metalloprotease of the astacin family and metzincin superfamily. This isoform of meprin is composed of disulfide-bonded dimers of ␣ subunits that further associate to form large, secreted megadalton complexes of 10 or more subunits. The aim of this study was to determine the sites of glycan attachment and to assess their ability to affect the formation and stability of the homo-oligomer. Nine of the ten potential N-linked glycosylation sites (Asn-41, Asn-152, Asn-234, Asn-270, Asn-330, Asn-426, Asn-452, Asn-546, and Asn-553) were found to be glycosylated in recombinant mouse meprin A using chemical and enzymatic deglycosylation methods and electrospray ionization mass spectrometry. Chemical cross-linking demonstrated that carbohydrates are at or near the noncovalent subunit interface. The removal of two glycans in the protease domain at Asn-234 and Asn-270, as well as one in the tumor necrosis factor receptor-associated factor domain at Asn-452, by a deglycosidase under nondenaturing conditions decreased the chemical and thermal stability of the homo-oligomer without affecting quaternary structure. Site-directed mutagenesis demonstrated that no single glycan was essential for oligomer formation; however, the combined absence of the glycans at Asn-152 and Asn-270 in the protease domain hindered intersubunit disulfide bond formation, prevented noncovalent associations, and abolished enzymatic activity. These studies provide insights into the role of glycans in the biosynthesis, activity, and stability of this extracellular protease.With a molecular mass of 1-8 MDa, the meprin A homooligomer is the largest known secreted protease (1, 2). It forms unique crescent, ring, barrel, and spiral structures through both disulfide bonds and noncovalent associations, and it is composed of ␣ subunits that have a monomeric molecular mass of 78 -85 kDa depending on the species (1, 3). Meprin A is secreted as an oligomer from the brush border epithelial cells of the kidneys and the intestine, as well as certain leukocytes and cancer cells (4 -8). Oligomerization of meprin A serves to concentrate the proteolytic activity of the ␣ subunit in the extracellular space for potential delivery to downstream targets in the kidney and intestinal lumen or for degradation of extracellular matrix proteins during leukocyte migration and cancer metastasis (2,6,7,9). In addition, mutants that are not oligomeric are much less stable than the wild type, and this may serve to protect the protein from the harsh extracellular milieu (10, 11).The folding and oligomerization process of the meprin A homo-oligomer is influenced by several factors within the ␣ subunit. Mutagenesis of His-167, a zinc ligand in the protease domain, leads to a monomeric, inactive protein (11). The MAM 4 (meprin, A5 protein, protein-tyrosine phosphatase ) and tumor necrosis factor receptor-associated factor (TRAF) domains are noncatalytic, but their presence is required for the secretion of a stable and active...